Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies

Raffaele Frazzi, Charles Auffray, Angela Ferrari, Perla Filippini, Sergio Rutella, Alfredo Cesario

Research output: Contribution to journalReview article

Abstract

Although survival rates for lymphoproliferative disorders are steadily increasing both in the US and in Europe, there is need for optimizing front-line therapies and developing more effective salvage strategies. Recent advances in molecular genetics have highlighted the biological diversity of lymphoproliferative disorders. In particular, integrative approaches including whole genome sequencing, whole exome sequencing, and transcriptome or RNA sequencing have been instrumental to the identification of molecular targets for treatment. Herein, we will discuss how genomic, epigenomic and proteomic approaches in lymphoproliferative disorders have supported the discovery of molecular lesions and their therapeutic targeting in the clinic.

Original languageEnglish
Article number252
JournalJournal of Translational Medicine
Volume14
Issue number1
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Integrative Medicine
Salvaging
Lymphoproliferative Disorders
Biodiversity
Systems Analysis
Medicine
Genes
RNA
Exome
RNA Sequence Analysis
Neoplasms
Transcriptome
Epigenomics
Proteomics
Molecular Biology
Genome
Therapeutics
Genetics

Keywords

  • High throughput RNA sequencing
  • Lymphoproliferative disorder
  • Massively-Parallel sequencing
  • Systems medicine

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies. / Frazzi, Raffaele; Auffray, Charles; Ferrari, Angela; Filippini, Perla; Rutella, Sergio; Cesario, Alfredo.

In: Journal of Translational Medicine, Vol. 14, No. 1, 252, 01.09.2016.

Research output: Contribution to journalReview article

Frazzi, Raffaele ; Auffray, Charles ; Ferrari, Angela ; Filippini, Perla ; Rutella, Sergio ; Cesario, Alfredo. / Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies. In: Journal of Translational Medicine. 2016 ; Vol. 14, No. 1.
@article{03fda73b6e544b53912065572ccf3b38,
title = "Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies",
abstract = "Although survival rates for lymphoproliferative disorders are steadily increasing both in the US and in Europe, there is need for optimizing front-line therapies and developing more effective salvage strategies. Recent advances in molecular genetics have highlighted the biological diversity of lymphoproliferative disorders. In particular, integrative approaches including whole genome sequencing, whole exome sequencing, and transcriptome or RNA sequencing have been instrumental to the identification of molecular targets for treatment. Herein, we will discuss how genomic, epigenomic and proteomic approaches in lymphoproliferative disorders have supported the discovery of molecular lesions and their therapeutic targeting in the clinic.",
keywords = "High throughput RNA sequencing, Lymphoproliferative disorder, Massively-Parallel sequencing, Systems medicine",
author = "Raffaele Frazzi and Charles Auffray and Angela Ferrari and Perla Filippini and Sergio Rutella and Alfredo Cesario",
year = "2016",
month = "9",
day = "1",
doi = "10.1186/s12967-016-1018-2",
language = "English",
volume = "14",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies

AU - Frazzi, Raffaele

AU - Auffray, Charles

AU - Ferrari, Angela

AU - Filippini, Perla

AU - Rutella, Sergio

AU - Cesario, Alfredo

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Although survival rates for lymphoproliferative disorders are steadily increasing both in the US and in Europe, there is need for optimizing front-line therapies and developing more effective salvage strategies. Recent advances in molecular genetics have highlighted the biological diversity of lymphoproliferative disorders. In particular, integrative approaches including whole genome sequencing, whole exome sequencing, and transcriptome or RNA sequencing have been instrumental to the identification of molecular targets for treatment. Herein, we will discuss how genomic, epigenomic and proteomic approaches in lymphoproliferative disorders have supported the discovery of molecular lesions and their therapeutic targeting in the clinic.

AB - Although survival rates for lymphoproliferative disorders are steadily increasing both in the US and in Europe, there is need for optimizing front-line therapies and developing more effective salvage strategies. Recent advances in molecular genetics have highlighted the biological diversity of lymphoproliferative disorders. In particular, integrative approaches including whole genome sequencing, whole exome sequencing, and transcriptome or RNA sequencing have been instrumental to the identification of molecular targets for treatment. Herein, we will discuss how genomic, epigenomic and proteomic approaches in lymphoproliferative disorders have supported the discovery of molecular lesions and their therapeutic targeting in the clinic.

KW - High throughput RNA sequencing

KW - Lymphoproliferative disorder

KW - Massively-Parallel sequencing

KW - Systems medicine

UR - http://www.scopus.com/inward/record.url?scp=84984671956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984671956&partnerID=8YFLogxK

U2 - 10.1186/s12967-016-1018-2

DO - 10.1186/s12967-016-1018-2

M3 - Review article

VL - 14

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 252

ER -